7-(tert-Butoxycarbonyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-d][1,4]diazepine-3-carboxylic acid, 95+%, 100mg

(R)-(5-Bromo-2-fluorophenyl)(cyclopropyl)methanamine, 98%, 100mg

1-(3-Nitrobenzyl)piperidin-4-amine dihydrochloride, 95.0%, 100mg

7,8-Dihydroquinoline-2,5(1H,6H)-dione, 95.0%, 10g

Pièce de transition avec olive Tube droit olive, 14/23, 1 Pièce

4-(1,1,3,3-tetramethylbutyl)benzene-1,3-diol, 99.0%, 5g

2-Methyl-3-trifluoromethylbenzoic acid, 97.0%, 5g

1-(Diphenylmethyl)-3-(hydroxymethyl)azetidine, 95.0%, 100g

(11bS)-2,6-Bis(3,5-difluorophenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 98%, 1g

2,3-Dihydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester, 98+%, 5g

Symbole d'avertissement selon ISO 7010 Étiquette individuelle, Basse température/gel, Longueur de côté 100 mm, 1 pièce

Butyl Levulinate>98.0%(GC)500mL

5-Bromo-2-phenyloxazole, 95.0%, 1g